HSBC Holdings’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,224
Closed -$686K 2904
2025
Q4
$686K Buy
17,224
+2,028
+13% +$74.3K ﹤0.01% 2154
2025
Q3
$535K Sell
15,196
-2,847
-16% -$98.1K ﹤0.01% 2070
2025
Q2
$583K Sell
18,043
-7,549
-29% -$245K ﹤0.01% 2067
2025
Q1
$827K Sell
25,592
-1,845
-7% -$68.5K ﹤0.01% 1831
2024
Q4
$833K Buy
27,437
+3,805
+16% +$122K ﹤0.01% 1899
2024
Q3
$667K Sell
23,632
-78,978
-77% -$1.95M ﹤0.01% 1869
2024
Q2
$2.38M Buy
102,610
+43,466
+73% +$1M ﹤0.01% 1333
2024
Q1
$1.8M Buy
59,144
+35,226
+147% +$1.18M ﹤0.01% 1531
2023
Q4
$857K Buy
23,918
+6,772
+39% +$252K ﹤0.01% 1836
2023
Q3
$750K Buy
17,146
+4,697
+38% +$229K ﹤0.01% 1818
2023
Q2
$620K Sell
12,449
-1,466
-11% -$67.6K ﹤0.01% 1905
2023
Q1
$578K Buy
13,915
+4,963
+55% +$206K ﹤0.01% 1991
2022
Q4
$395K Buy
+8,952
New +$374K ﹤0.01% 2389
2022
Q3
Sell
-17,325
Closed -$705K 2930
2022
Q2
$705K Buy
17,325
+7,710
+80% +$365K ﹤0.01% 2122
2022
Q1
$631K Buy
9,615
+3,885
+68% +$252K ﹤0.01% 2242
2021
Q4
$397K Buy
5,730
+175
+3% +$12.7K ﹤0.01% 2601
2021
Q3
$388K Sell
5,555
-306
-5% -$23.5K ﹤0.01% 2403
2021
Q2
$467K Buy
+5,861
New +$426K ﹤0.01% 2229
2021
Q1
Sell
-4,145
Closed -$231K 2726
2020
Q4
$231K Buy
+4,145
New +$179K ﹤0.01% 2728
2019
Q4
Sell
-53,729
Closed -$1.34M 3028
2019
Q3
$1.34M Buy
+53,729
New +$1.53M ﹤0.01% 1802

Other funds holding ATRC

HSBC Holdings's ATRC Position: Q1 2026 in Review

HSBC Holdings sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 17,224 shares — an estimated $686K sold.

HSBC Holdings first reported a position in ATRC in Q3 2019 and held it in 20 quarters. The position peaked at $2.38M in Q2 2024. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

  • HSBC Holdings reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
  • HSBC Holdings sold 17,224 AtriCure shares in Q1 2026, an estimated $686K.
  • HSBC Holdings first reported a position in AtriCure in Q3 2019 and held it in 20 quarters.
  • HSBC Holdings's AtriCure position peaked at $2.38M in Q2 2024.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.